版本:
中国

BRIEF-Sensorion selects new drug for disorders with inner ear lesions

Sept 29 Sensorion SA :

* Sensorion selects new drug candidate, SENS-401, to treat vestibular and auditory disorders associated with inner ear lesions

* SENS-401 will also strengthen sensorion's intellectual property portfolio, and company has filed new patent applications to seek commercial exclusivity for SENS-401 until 2036

* Sensorion has decided to select SENS-401, instead of 218, as its final drug candidate for treating lesions of inner ear Source text for Eikon: Further company coverage: (Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐